Shenzhen Salubris Renews Hong Kong Listing Bid With Updated Filing

Stock News

Yesterday

Shenzhen Salubris Pharmaceuticals Co., Ltd. has announced that it is actively advancing its plans to issue overseas-listed shares (H-shares) and pursue a main board listing on The Stock Exchange of Hong Kong Limited.

As part of this process and in line with the requirements of the Hong Kong exchange, the company submitted an updated listing application on September 3, 2026, and simultaneously published the revised application documents on the HKEX website.

The filing materials, prepared according to the guidelines of both the Hong Kong Securities and Futures Commission and the HKEX, are draft versions. Information contained within these documents may be subject to further updates and amendments in due course.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/news/1129275112"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129275112\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129275112?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-03 19:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129275112","market":"us","top_or_hot":-1,"title":"Shenzhen Salubris Renews Hong Kong Listing Bid With Updated Filing","media":"Stock News","content":"<p><b>Shenzhen Salubris Pharmaceuticals Co., Ltd.</b> has announced that it is actively advancing its plans to issue overseas-listed shares (H-shares) and pursue a main board listing on The Stock Exchange of Hong Kong Limited.<br><br>As part of this process and in line with the requirements of the Hong Kong exchange, the company submitted an updated listing application on September 3, 2026, and simultaneously published the revised application documents on the HKEX website.<br><br>The filing materials, prepared according to the guidelines of both the Hong Kong Securities and Futures Commission and the HKEX, are draft versions. Information contained within these documents may be subject to further updates and amendments in due course.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shenzhen Salubris Renews Hong Kong Listing Bid With Updated Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShenzhen Salubris Renews Hong Kong Listing Bid With Updated Filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-09-03 19:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Shenzhen Salubris Pharmaceuticals Co., Ltd.</b> has announced that it is actively advancing its plans to issue overseas-listed shares (H-shares) and pursue a main board listing on The Stock Exchange of Hong Kong Limited.<br><br>As part of this process and in line with the requirements of the Hong Kong exchange, the company submitted an updated listing application on September 3, 2026, and simultaneously published the revised application documents on the HKEX website.<br><br>The filing materials, prepared according to the guidelines of both the Hong Kong Securities and Futures Commission and the HKEX, are draft versions. Information contained within these documents may be subject to further updates and amendments in due course.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0188","symbol_name":"融资融券","start_time":0,"source_url":"","article_id":"1129275112","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129275112","pubTimestamp":1788436166,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shenzhen Salubris Pharmaceuticals Co., Ltd. has announced that it is actively advancing its plans to issue overseas-listed shares (H-shares) and pursue a main board listing on The Stock Exchange of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0188":"融资融券","BK0196":"行业龙头","BK0187":"一线龙头","BK0183":"MSCI概念","IPOS":"Renaissance International IPO ETF","BK0028":"国家队","BK0239":"医药制造","002294":"信立泰"},"translate_title":"深圳 Salubris 更新香港上市申请并更新备案文件","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002294":1,"IPOS":1},"content_text":"Shenzhen Salubris Pharmaceuticals Co., Ltd. has announced that it is actively advancing its plans to issue overseas-listed shares (H-shares) and pursue a main board listing on The Stock Exchange of Hong Kong Limited.As part of this process and in line with the requirements of the Hong Kong exchange, the company submitted an updated listing application on September 3, 2026, and simultaneously published the revised application documents on the HKEX website.The filing materials, prepared according to the guidelines of both the Hong Kong Securities and Futures Commission and the HKEX, are draft versions. Information contained within these documents may be subject to further updates and amendments in due course.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}